Congenital Adrenal Hyperplasia: Clinical Trials

66 trials for Congenital Adrenal Hyperplasia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

29 completed, 10 unknown, 9 recruiting, 5 terminated. 20 Phase 2, 10 Phase 3, 9 Phase 1, 5 Not applicable, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 220Completed 7, Recruiting 4, Terminated 4, Active not recruiting 2, Not yet recruiting 1, Unknown 1, Withdrawn 1
Phase 310Completed 4, Active not recruiting 2, Recruiting 2, Unknown 1, Withdrawn 1
Phase 19Completed 5, Active not recruiting 1, Recruiting 1, Terminated 1, Withdrawn 1
Not applicable5Completed 2, Not yet recruiting 1, Unknown 1, Withdrawn 1
Phase 42Recruiting 1, Unknown 1

Follow Congenital Adrenal Hyperplasia: new trials by email Literature Review of Congenital Adrenal Hyperplasia trials Research Report on Congenital Adrenal Hyperplasia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Development of Healthcare Transition for Patients With Congenital Adrenal Hyperplasia
exposure to healthcare transition protocol - Congenital Adrenal Hyperplasia
Not yet recruitingUniversity of Alabama at Birmingham402027-01-012026-10-14
Efficacy, Safety, Tolerability, and Pharmacokinetics of NBIP-01435 in Adult Participants With Classic Congenital Adrenal Hyperplasia (CAH)
NBIP-01435 - Congenital Adrenal Hyperplasia
Phase 2Not yet recruitingNeurocrine Biosciences362026-12-012026-09-30
Evaluation of Circadian Hormonal Balance: LC-MS/MS Measurement of Salivary and Serum Steroids in Patients With Congenital Adrenal Hyperplasia
Congenital Adrenal Hyperplasia, Adrenal Insufficiency
Not yet recruitingAssistance Publique - Hôpitaux de Paris502026-09-012026-07-21
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Crinecerfont in Participants With Classic Congenital Adrenal Hyperplasia (CAH) Who Are Less Than 4 Years Old
Crinecerfont - Congenital Adrenal Hyperplasia
Phase 2RecruitingNeurocrine Switzerland GmbH202026-07-012026-09-16
A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)
Atumelnant, Placebo - Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia
Phase 2 / Phase 3RecruitingCrinetics Pharmaceuticals Inc.1532026-01-222026-11-10
A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia
Atumelnant, Placebo - Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia
Phase 3RecruitingCrinetics Pharmaceuticals Inc.1502025-12-112026-11-10
A Study of a Virtual Education-Based Transition Intervention to Improve Transition Readiness in Adolescent and Young Adults With Congenital Adrenal Hyperplasia
virtual educational based transition intervention self-paced - Congenital Adrenal Hyperplasia
Not applicableWithdrawnNational Institutes of Health Clinical Center (CC)2025-12-092025-12-10
Pharmacokinetics, Safety and Tolerability of Crinecerfont in Participants With Congenital Adrenal Hyperplasia Who Are Less Than 2 Years Old
Crinecerfont - Congenital Adrenal Hyperplasia
Phase 2Active not recruitingNeurocrine Switzerland GmbH72025-09-302026-08-28
An Extension Study to Evaluate Safety and Efficacy of Atumelnant in Participants With Congenital Adrenal Hyperplasia
atumelnant (CRN04894) - Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia
Phase 2RecruitingCrinetics Pharmaceuticals Inc.2002025-02-252026-06-29
Investigation of the Etiology of Hypertension and Endothelial Damage in Patients With Cytochrome P450 Oxidoreductase Deficiency
Cytochrome P450 Oxidoreductase Deficiency, Hypertension
CompletedOzge Bayrak Demirel512024-12-242025-09-08
Growing up With the Young Endocrine Support System (YESS!)
YESS! game, Snake '97, Transition-toolkit - Congenital Adrenal Hyperplasia, Hypogonadotropic Hypogonadism
Not applicableNot yet recruitingdr. Laura C. G. de Graaff-Herder1602024-12-012023-09-07
Testicular Adrenal Rest Tumor in Congenital Adrenal Hyperplasia Patients Attending Assuit University Children Hospital
Testicular Adrenal Rest Tumor, Congenital Adrenal Hyperplasia
UnknownAssiut University302024-10-012024-08-21
Institutional Registry of Rare Diseases
Rare Diseases, Amyloidosis
RecruitingHospital Italiano de Buenos Aires3802024-07-012026-01-14
Exercise Capacity, Physical Fitness, and Physical Activity Levels in Children With CAH
Congenital Adrenal Hyperplasia, Exercise Capacity
CompletedHacettepe University482024-02-222025-07-08
Evaluate the Safety, Efficacy, and Pharmacokinetics of CRN04894 in Participants With Congenital Adrenal Hyperplasia (TouCAHn)
atumelnant (CRN04894) - Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia
Phase 2CompletedCrinetics Pharmaceuticals Inc.382023-07-032026-09-10
Androgen Reduction in Congenital Adrenal Hyperplasia
Abiraterone acetate, Placebo, Hydrocortisone - Congenital Adrenal Hyperplasia
Phase 2WithdrawnUniversity of Texas Southwestern Medical Center2023-01-012023-02-01
A Trial of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia
Lu AG13909 - Congenital Adrenal Hyperplasia
Phase 1 / Phase 2RecruitingH. Lundbeck A/S422022-12-192026-03-09
Baby Detect : Genomic Newborn Screening
Congenital Adrenal Hyperplasia, Familial Hyperinsulinemic Hypoglycemia 1
CompletedCentre Hospitalier Universitaire de Liege68242022-09-012025-08-12
Electronic Registry of Male Patients With Congenital Adrenal Hyperplasia 21-hydroxylase Deficiency
Congenital Adrenal Hyperplasia
RecruitingIRCCS Azienda Ospedaliero-Universitaria di Bologna302022-06-242024-12-31
Comparison of Chronocort Versus Standard Hydrocortisone Replacement Therapy in Participants Aged 16 Years and Over With Congenital Adrenal Hyperplasia
Chronocort, Cortef, Placebo - Congenital Adrenal Hyperplasia
Phase 3CompletedNeurocrine UK Limited552022-05-242026-10-02

Showing 20 of 66. Sign in to see all of them.

Narrower conditions

Adrenal Hyperplasia, Congenital (66)  ·  Adrenal Insufficiency (7)  ·  Disorders of Sex Development (7)  ·  Adrenal Gland Diseases (5)  ·  Congenital adrenal hyperplasia due to 21 hydroxylase deficiency (5)  ·  Cushing Syndrome (3)  ·  Ovotesticular Disorders of Sex Development (3)  ·  Adrenocortical Hyperfunction (2)  ·  Adrenogenital Syndrome (2)  ·  Combined Pituitary Hormone Deficiency (2)  ·  Dwarfism, Pituitary (2)  ·  Endocrine System Diseases (2)  ·  Gaucher Disease (2)  ·  Genetic Diseases, Inborn (2)  ·  Hepatolenticular Degeneration (2)

Broader conditions

Female Urogenital Diseases (66)  ·  Female Urogenital Diseases and Pregnancy Complications (66)  ·  Male Urogenital Diseases (66)  ·  Nutritional and Metabolic Diseases (66)  ·  Urogenital Diseases (66)  ·  Congenital Abnormalities (65)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (65)  ·  Gonadal Disorders (65)  ·  Metabolic Diseases (65)  ·  Adrenogenital Syndrome (64)  ·  Endocrine System Diseases (64)  ·  Genetic Diseases, Inborn (64)  ·  Metabolism, Inborn Errors (64)  ·  Steroid Metabolism, Inborn Errors (64)  ·  Urogenital Abnormalities (64)

Interventions

Hydrocortisone (8)  ·  Dexamethasone (4)  ·  Prednisone (4)  ·  crinecerfont (4)  ·  Prednisolone (3)  ·  Abiraterone Acetate (2)  ·  Interviews as Topic (2)  ·  Blood Specimen Collection (1)  ·  Cortisone (1)  ·  Exercise (1)  ·  Fludrocortisone (1)  ·  N-(2,6-bis(1-methylethyl)phenyl)-N'-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride (1)  ·  NBI 77860 (1)  ·  Nifedipine (1)  ·  Pioglitazone (1)

Sponsors

Neurocrine UK Limited (8)  ·  Spruce Biosciences (5)  ·  Crinetics Pharmaceuticals Inc. (4)  ·  Neurocrine Biosciences (4)  ·  Adrenas Therapeutics Inc (2)  ·  Ain Shams University (2)  ·  Assistance Publique - Hôpitaux de Paris (2)  ·  Assiut University (2)  ·  Hospices Civils de Lyon (2)  ·  IRCCS Azienda Ospedaliero-Universitaria di Bologna (2)  ·  Neurocrine Switzerland GmbH (2)  ·  Shanghai Jiao Tong University School of Medicine (2)  ·  University of Texas Southwestern Medical Center (2)  ·  dr. Laura C. G. de Graaff-Herder (2)  ·  Centre Hospitalier Universitaire de Liege (1)

Countries

United States (34)  ·  France (13)  ·  Italy (12)  ·  United Kingdom (12)  ·  Germany (9)  ·  Brazil (7)  ·  Netherlands (7)  ·  Poland (7)  ·  Sweden (7)  ·  Spain (6)  ·  Argentina (5)  ·  Belgium (5)  ·  Canada (5)  ·  Australia (4)  ·  Turkey (Türkiye) (4)

Top investigators

Perrin C White, MD (2)  ·  Adrian Gadano, MD (1)  ·  Alessandra Gambineri, MD (1)  ·  Anne Bachelot, MD, PhD (1)  ·  Arpana G Inman (1)  ·  Catherine Cornu, MD (1)  ·  Christy Foster, MD (1)  ·  Cornelis J Tack, MD, PhD (1)  ·  D Merke (1)  ·  David E Sandberg, PhD (1)  ·  Debbie Merke, MD (1)

Results publications

PMID 33527139, PMID 34146101, PMID 20719839, PMID 23337727, PMID 24878054, PMID 25494662, PMID 32589738, PMID 33278125, PMID 35283460, PMID 37343084, PMID 38828945, PMID 38828955

NIH funding

2023 (3), 2019 (1), M01RR001070 (1), R01HD057930 (1), U01HD083493 (1)